Screening compound: InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3

Screening compound: InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3
Screening compound: InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S434-0141

Molecular Formula

C16H21N5OS (C16 H21 N5 OS)

Compound Name

4-[6-methyl-2-(pyrrolidine-1-carbonyl)pyrazolo[1,5-a]pyrazin-4-yl]thiomorpholine

IUPAC name

4-[6-methyl-2-(pyrrolidine-1-carbonyl)pyrazolo[15-a]pyrazin-4-yl]thiomorpholine

SMILES

Cc(nc(c1c2)N3CCSCC3)cn1nc2C(N1CCCC1)=O

InChI

InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3

InChI Key

PUJUGUJXVWDBDH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29005812

InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS BBB Library (22607 compounds)

CNS MPO Library (28609 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Soluble Diversity Library (15920 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Nervous system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Mechanism of action:
  • PPI modulators
  • Epigenetic
Targets:
  • Others

References: we are preparing a list of scientific research reports with InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3?
Check Price and Availability of InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C16H21N5OS/c1-12-11-21-14(15(17-12)19-6-8-23-9-7-19)10-13(18-21)16(22)20-4-2-3-5-20/h10-11H,2-9H2,1H3 available by request